Press Releases

• 2026 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant Recipient Announced July 22, 2026
  Rebecca Snyder, MD, Awarded LEAD Grant to Advance AI-Powered Clinical Trial Matching for Pancreatic Cancer The Lustgarten Foundation today announced a new Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant awarded to co-investigators Rebecca Snyder, MD, MPH, Associate Professor of Surgical Oncology, and Heather G. Lyu, MD, MBI, Assistant Professor in the Department of Surgical… Read more: 2026 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant Recipient Announced 
• The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-Targeted Immunotherapy Strategy for Pancreatic CancerJuly 22, 2026
  Newly recruiting Phase 1 study will evaluate a next-generation KRAS-targeted immunotherapy, revealing how pancreatic tumor microenvironment shapes treatment response The Lustgarten Foundation and Break Through Cancer today announced the launch of a new Phase 1 clinical trial evaluating a next-generation KRAS-targeted lymph-node stimulating immunotherapy strategy for pancreatic cancer. The study is now recruiting patients with… Read more: The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-Targeted Immunotherapy Strategy for Pancreatic Cancer
• The Lustgarten Foundation Receives Strategic Grant from the Cinelli Family Foundation to Advance the LUCID PlatformJuly 20, 2026
  $350,000 gift will accelerate a data-sharing platform designed to transform pancreatic cancer research and improve patient outcomes The Lustgarten Foundation today announced a $350,000 gift from the Cinelli Family Foundation to support the continued development of the Lustgarten United Clinical Information Database (LUCID), a platform built to give researchers shared access to high-quality clinical data… Read more: The Lustgarten Foundation Receives Strategic Grant from the Cinelli Family Foundation to Advance the LUCID Platform
• 17th Annual Lustgarten Foundation Westchester Walk for Pancreatic Cancer ResearchJuly 16, 2026
  The Lustgarten Foundation Westchester Walk for Pancreatic Cancer, presented by Northwell Cancer Institute, draws nearly 300 supporters and raises more than $129,000 Nearly 300 community members gathered on Sunday, June 14th,  at Westchester Community College for the 17th Annual Lustgarten Foundation Westchester Walk for Pancreatic Cancer Research, presented by the Northwell Cancer Institute. Together, participants… Read more: 17th Annual Lustgarten Foundation Westchester Walk for Pancreatic Cancer Research
• 2026 Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced July 13, 2026
  CAI grants awarded to Ashwin Somasundaram, MD, Harshabad Singh, MBBS, MD, Mark O’Hara, MD, and Anirban Maitra, MD  UNIONDALE, N.Y., June 30, 2026 — The Lustgarten Foundation has announced four new Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative (CAI) grants awarded to Ashwin Somasundaram, MD, Assistant Professor of Medicine at the University of North… Read more: 2026 Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced 
• 2026 Career Development Awards Announced June 25, 2026
  2026 Lustgarten Foundation-AACR Career Development Award recipients an Announced at 2026  AACR Annual Meeting UNIONDALE, NY, June 25, 2026 – The Lustgarten Foundation, in collaboration with the American Association for Cancer Research (AACR), has announced the 2026 recipients of the Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in honor of Ruth Bader Ginsburg… Read more: 2026 Career Development Awards Announced 
• The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope GalaJune 15, 2026
  NEW YORK, NY, June 15, 2026 – On Wednesday, June 3, the Lustgarten Foundation welcomed supporters, researchers, physicians, industry leaders, and philanthropic partners to its annual Inspiring Hope Gala at Peak at The Edge in Hudson Yards. The event celebrated the scientific momentum that is reshaping the future of pancreatic cancer care and the leadership,… Read more: The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope Gala
• The System that Delivered the Possibility of mRNA Cancer Vaccines is Being DismantledMay 13, 2026
  For years, pancreatic cancer has been considered immune to immunotherapy. Its tumors were “cold”—invisible to the body’s natural defenses and resistant to treatments that worked against other cancers. Patients had fewer options and less hope. Jump to Updates Then Dr. Vinod Balachandran at Memorial Sloan Kettering asked a different question: What if pancreatic cancer wasn’t… Read more: The System that Delivered the Possibility of mRNA Cancer Vaccines is Being Dismantled
• A New Era in Pancreatic Cancer: How Personalized mRNA Vaccines are Changing What’s PossibleApril 21, 2026
  For decades, pancreatic cancer has remained one of the most difficult cancers to treat. Too often diagnosed late and resistant to many standard therapies, it has long demanded new thinking, bold science, and sustained investment. Today, one of the most exciting breakthroughs in pancreatic cancer research is making national headlines: personalized mRNA vaccines designed to… Read more: A New Era in Pancreatic Cancer: How Personalized mRNA Vaccines are Changing What’s Possible
• A Turning Point in Pancreatic Cancer: DaraxonrasibApril 15, 2026
  UPDATE (5/12/2026): Following last week’s announcement of expanded access for daraxonrasib in pancreatic cancer, Revolution Medicines has now shared additional information and guidelines for physicians and patients interested in the program. We encourage patients and caregivers to speak with their care teams to determine whether expanded access may be appropriate for their individual situation.Learn more… Read more: A Turning Point in Pancreatic Cancer: Daraxonrasib
• The Power of Persistence: Ecosystem Thinking and Career Leadership in Cancer Research April 15, 2026
  The Lustgarten Foundation’s annual International Women’s Day symposium, The Power of Persistence: Women Transforming Cancer Research and Care, highlights women’s critical role in advancing innovation in the fight against cancer. Co-chaired by Lisa Coussens and Elizabeth Jaffee, the event celebrates women’s achievements while fostering collaboration, mentorship, and the exchange of ideas, providing a platform where shared… Read more: The Power of Persistence: Ecosystem Thinking and Career Leadership in Cancer Research 
• Statement on the NHS–GRAIL Galleri TrialFebruary 23, 2026
  We were disappointed to learn that the Galleri multi-cancer early detection (MCED) test, developed by GRAIL, did not meet the primary endpoint in its large randomized trial conducted in partnership with the National Health Service (NHS).¹ The study was designed to determine whether use of the Galleri test could shift cancer diagnoses from late stage… Read more: Statement on the NHS–GRAIL Galleri Trial
• Coalition to Accelerate Early Detection of Deadly CancersFebruary 11, 2026
  While cancer mortality rates in the United States have steadily declined over recent decades, a group of recalcitrant cancers remains stubbornly lethal. For diseases like pancreatic, ovarian, and upper GI cancers, the primary barrier to survival is not just the biology of the tumor, but the timing of the diagnosis. To combat this pressing issue,… Read more: Coalition to Accelerate Early Detection of Deadly Cancers
• Unlocking Early Detection: How Long-Term Investment Is Changing What’s Possible in Pancreatic CancerDecember 23, 2025
  WHY EARLY DETECTION IN PANCREATIC CANCER CAN’T WAIT For decades, pancreatic cancer has been defined by late diagnosis and limited options. The disease often progresses silently and aggressively, with symptoms appearing only after it has advanced – when treatment options are few and outcomes are poor. Earlier detection remains our single greatest opportunity to change survival and save lives.  This reality is… Read more: Unlocking Early Detection: How Long-Term Investment Is Changing What’s Possible in Pancreatic Cancer
• From Undruggable to Unstoppable: The State of KRAS Drug Development in Pancreatic CancerOctober 29, 2025
  WHAT KRAS MEANS AND WHY IT MATTERS KRAS is what scientists call an oncogene – a gene that, when mutated, can promote uncontrolled cell growth and lead to cancer. In its normal state, KRAS acts like an on/off switch that controls when cells divide. But when mutated, it can get stuck in the “on” position,… Read more: From Undruggable to Unstoppable: The State of KRAS Drug Development in Pancreatic Cancer
• The Lustgarten Foundation Gathered Nation’s Foremost Pancreatic Cancer Experts for Annual Scientific Advisory Board MeetingOctober 14, 2025
  COLD SPRING HARBOR, N.Y., Oct 10, 2025 – The Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research, convened its annual Scientific Advisory Board (SAB) Meeting on October 6 at the Banbury Center at Cold Spring Harbor Laboratory. Over three days, the nation’s leading pancreatic cancer experts reviewed progress across Lustgarten-funded projects, exchanged… Read more: The Lustgarten Foundation Gathered Nation’s Foremost Pancreatic Cancer Experts for Annual Scientific Advisory Board Meeting
• 25 YEARS STRONG: LUSTGARTEN FOUNDATION FLAGSHIP WALK UNITES LONG ISLAND COMMUNITY TO ADVANCE PANCREATIC CANCER RESEARCHOctober 7, 2025
  25th Annual Long Island Walk presented by Northwell Health Cancer Institute draws nearly 3,000 supporters & raises more than $826,000 and counting in support of pancreatic cancer research JONES BEACH, N.Y., Oct 07, 2025 – Nearly 3,000 Long Island residents touched by pancreatic cancer gathered for a morning of hope, remembrance, and action at Sunday’s… Read more: 25 YEARS STRONG: LUSTGARTEN FOUNDATION FLAGSHIP WALK UNITES LONG ISLAND COMMUNITY TO ADVANCE PANCREATIC CANCER RESEARCH
• Standing Up for Science: 8 Powerful Ways to Protect Pancreatic Cancer ResearchSeptember 29, 2025
  Federal funding cuts to cancer research are devastating—but we’re not giving up, and neither should you! Know the facts – Why it matters and who it hurts – In moments like this, our strength lies in our community. Your voice matters more than ever and when we speak up together, we’re a force for progress… Read more: Standing Up for Science: 8 Powerful Ways to Protect Pancreatic Cancer Research
• Lustgarten Foundation Appoints New Board MemberJuly 1, 2025
  Arthur Kuan, MS, joins the Lustgarten Foundation Board of Directors   UNIONDALE, NY, JUNE 30, 2025 – The Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research, today announced the appointment of Arthur Kuan, MS, to its Board of Directors. Mr. Kuan is the Chairman and Chief Executive Officer of CG Oncology, a clinical-stage… Read more: Lustgarten Foundation Appoints New Board Member
• 16th Annual Lustgarten Foundation Westchester Walk for Pancreatic Cancer ResearchJune 10, 2025
  The Lustgarten Foundation Westchester Walk for Pancreatic Cancer, presented by Northwell Health Cancer Institute, draws over 450 supporters and raises more than $136,000. Valhalla, NY, June 11, 2025 –More than 450 community members gathered on Sunday morning at Westchester Community College for the 16th Annual Lustgarten Foundation Westchester Walk for Pancreatic Cancer Research, presented by… Read more: 16th Annual Lustgarten Foundation Westchester Walk for Pancreatic Cancer Research
• 2025 Career Development Awards Announced May 19, 2025
  UNIONDALE, NY, May 16, 2025 – The Lustgarten Foundation, in collaboration with the American Association for Cancer Research (AACR), has announced the 2025 recipients of the Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in honor of Ruth Bader Ginsburg and John Robert Lewis. Grants were awarded to Anupriya Singhal, MD, PhD, Memorial Sloan… Read more: 2025 Career Development Awards Announced 
• THE LUSTGARTEN FOUNDATION HONORS REVOLUTION MEDICINES FOR TRANSFORMATIVE RESEARCH IN PANCREATIC CANCERMay 8, 2025
  Revolution Medicines receives inaugural Hope Through Science Award at annual gala, Inspiring Hope NEW YORK, NY, May 8, 2025 – On Wednesday, April 30, the Lustgarten Foundation presented the inaugural Hope Through Science Award to Revolution Medicines at its annual gala, Inspiring Hope. This prestigious award celebrates the company’s groundbreaking efforts to advance treatments for… Read more: THE LUSTGARTEN FOUNDATION HONORS REVOLUTION MEDICINES FOR TRANSFORMATIVE RESEARCH IN PANCREATIC CANCER
• Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced February 7, 2025
  CAI grants awarded to Gregory Beatty, MD, PhD, Dung Le, MD, and Kevin Soares, MD  UNIONDALE, N.Y., February 7, 2025 — The Lustgarten Foundation has announced three new Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative (CAI) grants awarded to Gregory Beatty, MD, PhD, Associate Professor of Medicine (Hematology-Oncology) at the University of Pennsylvania Perelman… Read more: Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced 
• Nina Steele, PhD, and Howard Crawford, PhD, of the Henry Ford Pancreatic Cancer Center, Awarded Lustgarten Grant Focusing on Racial Disparities in Pancreatic CancerJanuary 9, 2025
  UNIONDALE, N.Y., January 9, 2025 — The Lustgarten Foundation announced a new grant today, awarded to Nina Steele, PhD, and Howard Crawford, PhD, of the Henry Ford Pancreatic Cancer Center at Henry Ford Health. This 2-year grant, totaling $426,975, will support Drs. Steele and Crawford’s efforts to develop the world’s first fully de-identified, clinically annotated… Read more: Nina Steele, PhD, and Howard Crawford, PhD, of the Henry Ford Pancreatic Cancer Center, Awarded Lustgarten Grant Focusing on Racial Disparities in Pancreatic Cancer
• LUSTGARTEN FOUNDATION FLAGSHIP WALK INSPIRES COMMUNITY AND RAISES CRITICAL DOLLARS FOR PANCREATIC CANCER RESEARCHOctober 7, 2024
  24th Annual Long Island Walk presented by Northwell Health Cancer Institute draws over 2,000 supporters & raises more than $660,000 and counting in support of pancreatic cancer research  JONES BEACH, N.Y., Oct 07, 2024 – Long Island residents touched by pancreatic cancer gathered for a morning of hope, remembrance, and action at Sunday’s Walk for… Read more: LUSTGARTEN FOUNDATION FLAGSHIP WALK INSPIRES COMMUNITY AND RAISES CRITICAL DOLLARS FOR PANCREATIC CANCER RESEARCH
• The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer ResearchAugust 8, 2024
  UNIONDALE, NY, Aug 15, 2024 — The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a landmark year of funding, awarding ten new grants to researchers at seven leading institutions. These grants, totaling $10.7 million, support Lustgarten’s unique patient-centered mission which drives outcomes across three research pillars—early detection and interception,… Read more: The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer Research
• Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced July 29, 2024
  CAI grants awarded to Eric Christenson, MD, & Andrew Lowy, MD   WOODBURY, N.Y., July 30, 2024 — The Lustgarten Foundation has announced two new Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative (CAI) grants awarded to Eric Christenson, MD, Assistant Professor, Johns Hopkins University School of Medicine, for his study “A pilot study comparing neoadjuvant… Read more: Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced 
• Lustgarten Foundation Appoints Two New Board Members June 12, 2024
  Richard Barakat, MD, and Aaron Kantoff join the Lustgarten Foundation Board of Directors   Woodbury, New York, June 11, 2024 – The Lustgarten Foundation, the largest private funder of pancreatic cancer research in the world, today announced the appointment of two new board members: Richard Barakat, MD, and Aaron Kantoff. Dr. Barakat is a world-renowned surgeon… Read more: Lustgarten Foundation Appoints Two New Board Members 
• Announcing the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant May 30, 2024
  Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, Awarded 2024 LEAD Project Grant   WOODBURY, N.Y., May 30, 2024 — The Lustgarten Foundation has announced that the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant will be awarded to Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, for his… Read more: Announcing the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant 
• Announcing the 2024 Innovation and Collaboration Program Grant Recipient May 28, 2024
  Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University, Awarded 2024 Innovation and Collaboration Program Grant   WOODBURY, N.Y., May 27, 2024 — The Lustgarten Foundation announced today that the 2024 Innovation and Collaboration Program grant will be awarded to Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University for… Read more: Announcing the 2024 Innovation and Collaboration Program Grant Recipient 
• The Lustgarten Foundation Receives $500,000 Gift from The Warren Alpert Foundation May 1, 2024
  The remarkable gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program.  WOODBURY, N.Y., May 1, 2024 — The Lustgarten Foundation today announced a remarkable $500,000 donation from The Warren Alpert Foundation. The generous gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program, which encourages researchers to explore promising avenues for understanding and treating… Read more: The Lustgarten Foundation Receives $500,000 Gift from The Warren Alpert Foundation 
• 14th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer Research  April 22, 2024
  Over 300 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in New York City  New York, N.Y., Apr 22, 2024 — Over 300 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in Manhattan on April 21 for a morning of hope, remembrance, and action to raise critical funds for the Lustgarten… Read more: 14th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer Research  
• New FDA Approval Brings More Treatment Options in Metastatic Disease February 14, 2024
  With thanks and appreciation to our contributing partner, Let’s Win Pancreatic Cancer. The U.S. Food and Drug Administration has approved irinotecan liposome (ONIVYDE) in combination with oxaliplatin, fluorouracil, and leucovorin, for the frontline treatment of metastatic pancreatic adenocarcinoma.   The combo, dubbed NALIRIFOX, has been shown to improve overall survival for a disease that has far… Read more: New FDA Approval Brings More Treatment Options in Metastatic Disease 
• Lustgarten Foundation receives $550,000 grant towards next phase of Organoids for Personalized Therapy (OPT) ProjectFebruary 13, 2024
  From devastation to dedication, Gail Coleman is committed to supporting personalized medicine in pancreatic cancer research. WOODBURY, NY, February 14, 2024 – Gail Coleman, a nine-year supporter of the Lustgarten Foundation, has generously committed a three-year gift totaling $550,000 to support the Organoids for Personalized Therapy (OPT) Project at the LABS (Lustgarten Advancing Breakthrough Science)… Read more: Lustgarten Foundation receives $550,000 grant towards next phase of Organoids for Personalized Therapy (OPT) Project
• 2024 Walks AnnouncedFebruary 5, 2024
  Find a Lustgarten Walk for Pancreatic Cancer Research near you!
• Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming yearJanuary 31, 2024
  According to a Lustgarten-funded study from Dana-Farber Cancer Institute WOODBURY, NY, January 31, 2024 — Last week, the Journal of the American Medical Association published results from a Lustgarten-funded study from the LABS (Lustgarten Advancing Breakthrough Science) Program site at Dana-Farber Cancer Institute, led by Brian Wolpin, M.D., MPH, Director of the Gastrointestinal Cancer Center… Read more: Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming year
• The Lustgarten Foundation Receives $1.5 Million Gift from The Bern Schwartz Family FoundationJanuary 26, 2024
  The generous gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program site at the Salk Institute for Biological Studies.  WOODBURY, N.Y., Jan 26, 2024 — The Lustgarten Foundation today announced an extraordinary $1.5 million gift from The Bern Schwartz Family Foundation. The generous donation will support the LABS (Lustgarten Advancing Breakthrough Science) Program site… Read more: The Lustgarten Foundation Receives $1.5 Million Gift from The Bern Schwartz Family Foundation
• The Lustgarten Foundation hosts Seeing Beyond, Lustgarten’s inaugural pancreatic cancer research symposium November 20, 2023
  Research pioneers, experts, and early career investigators unite LIVE in New York City for Seeing Beyond, honoring the organization’s 25th anniversary year.  NEW YORK, NY, November 20, 2023 – On Wednesday, November 15, 2023, The Lustgarten Foundation hosted their inaugural pancreatic cancer research symposium, Seeing Beyond. The Foundation is the largest private funder of pancreatic… Read more: The Lustgarten Foundation hosts Seeing Beyond, Lustgarten’s inaugural pancreatic cancer research symposium 
• Lustgarten Foundation Flagship Walk Inspires Community and Raises Critical Dollars for Pancreatic Cancer ResearchOctober 3, 2023
  23rd Annual Long Island Walk presented by Northwell Health Cancer Institute draws over 2,000 supporters & raises over $700,000 and counting in support of pancreatic cancer research. JONES BEACH, N.Y., Oct 01, 2023 – Long Island residents touched by pancreatic cancer gathered for a morning of hope, remembrance, and action at Sunday’s Walk for Pancreatic… Read more: Lustgarten Foundation Flagship Walk Inspires Community and Raises Critical Dollars for Pancreatic Cancer Research
• The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy ResearchSeptember 18, 2023
  (NEW YORK) – The Cancer Research Institute (CRI) and the Lustgarten Foundation have announced a new partnership focused exclusively on supporting pancreatic cancer immunotherapy research.    The partnership, INSPIRE (Integrated Network for Supporting Pancreatic Cancer Immunotherapy Research Efforts), will encompass the established and ongoing adaptive platform trial, REVOLUTION, evaluating first-line chemo-immunotherapy treatment combinations for patients… Read more: The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research
• The Lustgarten Foundation Announces Extraordinary Year of Research Grants Fueling Bold and Innovative Pancreatic Cancer ResearchAugust 2, 2023
  The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a remarkable year of funding, awarding 17 new grants to researchers at 13 leading institutions. These grants, totaling $23 million, support Lustgarten’s collaborative, science-focused strategy, which drives outcomes across three research pillars—early detection, new drug development, and personalized medicine. With the… Read more: The Lustgarten Foundation Announces Extraordinary Year of Research Grants Fueling Bold and Innovative Pancreatic Cancer Research
• Lustgarten Foundation Announces 2023 Innovation and Collaboration Program GrantsJuly 24, 2023
  Kacper Rogala, DPhil, MRes, Stanford University School of Medicine & David Kashatus, PhD, University of Virginia School of Medicine, Awarded 2023 Innovation and Collaboration Program Grants   WOODBURY, N.Y., July 24, 2023 — The Lustgarten Foundation announced today that the 2023 Innovation and Collaboration Program grants will be awarded to Kacper Rogala, DPhil, MRes, Assistant Professor… Read more: Lustgarten Foundation Announces 2023 Innovation and Collaboration Program Grants
• Lustgarten Foundation Announces the Appointment of Two New Board MembersJuly 13, 2023
  Selwyn M. Vickers, MD, FACS, and Scott Penberthy, PhD, MS, join the Lustgarten Foundation Board of Directors  Woodbury, New York, July 13, 2023 – The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced the appointment of two new board members: Selwyn M. Vickers, MD, FACS, and Scott Penberthy, PhD, MS.… Read more: Lustgarten Foundation Announces the Appointment of Two New Board Members
• Lustgarten-funded clinical trial yields promising results as the Journal Nature publishes findings: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.June 1, 2023
  In May 2023, the Journal Nature published promising results from a study funded by the Pancreatic Cancer Collective (PCC), a partnership between the Lustgarten Foundation and Stand Up To Cancer. This study was the culmination of years of research leading to the critical discovery that long-term pancreatic cancer survivors have specific immune responses that the… Read more: Lustgarten-funded clinical trial yields promising results as the Journal Nature publishes findings: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
• 2023 Lustgarten Foundation-AACR Career Development Awardees AnnouncedMay 15, 2023
  WOODBURY, NY – At the American Association for Cancer Research (AACR) Annual Meeting 2023, The Lustgarten Foundation and the AACR presented the Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis to Christina M. Ferrer, PhD, from the University of Maryland, Baltimore, Maryland, and Ashley… Read more: 2023 Lustgarten Foundation-AACR Career Development Awardees Announced
• 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant Recipients AnnouncedMay 12, 2023
  WOODBURY, N.Y., May 9, 2023 — The Lustgarten Foundation has announced that the 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grants will be awarded to Karyn Goodman, MD, MS, Vice Chair of Radiation Oncology and Associate Director of Clinical Research at Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, for her study… Read more: 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant Recipients Announced
• Andrew Rakeman, PhD, Lustgarten Foundation Vice President of Research, and Elizabeth Jaffee, MD, Lustgarten Foundation Chief Medical Advisor and Deputy Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Attend The Alma Mater Studiorum/Lustgarten Foundation Lecture in Bologna, Italy April 25, 2023
  Bologna, Italy – On April 3, 2023, Andrew Rakeman, PhD, and Elizabeth Jaffee, MD, attended the first ever Alma Mater Studiorum/Lustgarten Foundation Lecture in Bologna, Italy at the University of Bologna, led by Professor Riccardo Casadei, MD, Chief of the Pancreatic and Endocrine Surgical Division. The lecture entitled “Pancreatic Cancer: The Commitment of Breakthrough Science… Read more: Andrew Rakeman, PhD, Lustgarten Foundation Vice President of Research, and Elizabeth Jaffee, MD, Lustgarten Foundation Chief Medical Advisor and Deputy Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Attend The Alma Mater Studiorum/Lustgarten Foundation Lecture in Bologna, Italy 
• 13th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer ResearchApril 17, 2023
  Over 500 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in New York City  New York, N.Y. —Over 500 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in Manhattan on April 16 for a morning of hope, remembrance, and action to raise critical funds for the Lustgarten Foundation. Since its inception… Read more: 13th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer Research
• The Lustgarten Foundation Announces Grants to Elliot Fishman, MD, Johns Hopkins University School of Medicine & Alan Yuille, PhD, Johns Hopkins Whiting School of Engineering to Advance Pancreatic Cancer Detection EffortsMarch 15, 2023
  WOODBURY, N.Y., Mar 01, 2023 — The Lustgarten Foundation announced today that two grants will be awarded to Elliot Fishman, MD, Johns Hopkins University School of Medicine for his study FELIX 2.0. The Integration of AI into the Early Detection and Management of Pancreatic Cancer with Novel AI Algorithms and Advanced Data Analysis and Alan Yuille, PhD, Johns Hopkins Whiting… Read more: The Lustgarten Foundation Announces Grants to Elliot Fishman, MD, Johns Hopkins University School of Medicine & Alan Yuille, PhD, Johns Hopkins Whiting School of Engineering to Advance Pancreatic Cancer Detection Efforts
• 22nd ANNUAL WINTER BASH RAISES CRITICAL FUNDS FOR THE LUSTGARTEN FOUNDATION  February 17, 2023
  All Donations Fund Pancreatic Cancer Research    MSG Entertainment, MSG Sports, and AMC Networks Hosted Fundraiser   at Tao Downtown in New York City Featuring DJ Rumor and the Radio City Rockettes  NEW YORK, NY, February 17, 2023 – On Wednesday, February 15th, MSG Entertainment (NYSE: MSG), MSG Sports (NYSE: MSGS), and AMC Networks (NASDAQ: AMCX) hosted… Read more: 22nd ANNUAL WINTER BASH RAISES CRITICAL FUNDS FOR THE LUSTGARTEN FOUNDATION  

About Lustgarten Foundation  

The Lustgarten Foundation funds the world’s preeminent pancreatic cancer researchers, driving the pursuit of bold and innovative science toward earlier detection, better treatments and transforming pancreatic cancer into a curable disease. The Foundation is a catalyst—Lustgarten-funded science has been a driving force in every major advancement in pancreatic cancer research since 1998. We believe time is everything for pancreatic cancer patients and their families, so we fund research where creative risks yield high rewards to accelerate and expand life-saving treatment options. And we believe in the power of community. Lustgarten programs and events provide people affected by pancreatic cancer a voice and a place to create hope, together. The Lustgarten Foundation is the world’s largest private funder of pancreatic cancer research and 100% of all donations fuel the research to advance understanding of this complex, devastating and historically underfunded cancer. For more information, visit lustgarten.org.  

Follow us on social @LustgartenFDN: Facebook, Instagram Twitter and Youtube.
And @the-lustgarten-foundation on LinkedIn.